Scientists Identify TRAP1 as Key Driver of Prostate Cancer

About 1 in 7 men will be diagnosed with prostate cancer in their lifetimes, according to the American Cancer Society, making it the second-most common form of cancer in American men. Recently, a potentially promising new therapeutic target for the disease was identified by scientists from The Wistar Institute, one of Kerafast’s providing institutions. The 

Continue Reading…

New markers to assess Huntington’s disease progression

Huntington’s disease is a debilitating, progressive disease that is eventually fatal. Affecting nerves of the brain, Huntington’s disease (HD) deteriorates an individual’s mental and physical capabilities over time. A recent study published in The Journal of Experimental Medicine by Stanford University researchers identified potential biomarkers to assess disease progression and analyze treatment effectiveness. Huntington’s disease 

Continue Reading…

How the microbiota influences Crohn’s disease

Crohn’s disease (CD) is an inflammatory bowel disease that causes chronic inflammation of the gastrointestinal tract, most commonly in the small intestine. It is estimated that more than a half million people in the United States suffer from CD. The most common symptoms of Crohn’s disease include diarrhea, abdominal cramping and weight loss. The complications 

Continue Reading…